Cambridge Investment Research Advisors, Inc.
Position in NTRA — Natera, Inc.
CIK 1419186
FAIRFIELD, IA
Position in NTRA
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$721,785
+$178,013 QoQ
Shares Held
2,659
-2.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#482
of 844 holders
Holding Since
Dec 2024
7 quarters on record
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $56,202,312 across 19 Diagnostics & Research names. NTRA ranks #13 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
45,487 | $22,805,362 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
40,470 | $7,819,613 | |
| 3 | DHR |
Danaher Corp /De/
|
29,086 | $5,540,301 | |
| 4 | DGX |
Quest Diagnostics Inc
|
15,492 | $3,283,529 | |
| 5 | LH |
Labcorp Holdings Inc.
|
11,187 | $3,132,360 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
4,300 | $2,263,692 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
3,996 | $2,116,241 | |
| 8 | A |
Agilent Technologies, Inc.
|
11,896 | $1,580,145 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $721,785 | 2,659 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $543,772 | 2,719 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $519,805 | 2,269 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $367,333 | 2,282 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $660,555 | 3,910 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $239,124 | 1,691 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $265,785 | 1,679 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||